We are live on ! Find out more
CCXI

ChemoCentryx, Inc.

Delisted

CCXI was delisted on the 19th of October, 2022.

60 hedge funds and large institutions have $136M invested in ChemoCentryx, Inc. in 2013 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 19 increasing their positions, 16 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 12 (+1)

19% more repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 16

16% more capital invested

Capital invested by funds: $117M → $136M (+$19M)

9% less funds holding

Funds holding: 6660 (-6)

27% less first-time investments, than exits

New positions opened: 16 | Existing positions closed: 22

83% less call options, than puts

Call options by funds: $36K | Put options by funds: $214K

Holders
60
Holders Change
-6
Holders Change %
-9.09%
% of All Funds
1.74%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.06%
New
16
Increased
19
Reduced
16
Closed
22
Calls
$36K
Puts
$214K
Net Calls
-$178K
Net Calls Change
+$913K
Name Holding Trade Value Shares
Change
Change in
Stake
BI
1
BVF Inc
California
$45.1M +$12.5M +2,418,900 +45%
Capital World Investors
2
Capital World Investors
California
$18.1M
WA
3
Wasatch Advisors
Utah
$15.3M +$4.66M +903,807 +52%
BFA
4
BlackRock Fund Advisors
California
$6.72M +$2.39M +463,075 +66%
Balyasny Asset Management
5
Balyasny Asset Management
Illinois
$6.71M +$3.49M +676,213 +140%
BC
6
Broadfin Capital
New York
$5.99M +$5.33M +1,033,668 New
GPP
7
Great Point Partners
Connecticut
$5.79M +$5.16M +1,000,000 New
Franklin Resources
8
Franklin Resources
California
$5.02M
Vanguard Group
9
Vanguard Group
Pennsylvania
$3.65M +$789K +153,033 +32%
Renaissance Technologies
10
Renaissance Technologies
New York
$2.25M +$2M +387,880 New
State Street
11
State Street
Massachusetts
$1.91M -$603 -117 -0%
Northern Trust
12
Northern Trust
Illinois
$1.91M +$23.1K +4,480 +1%
RA
13
Royce & Associates
New York
$1.63M +$1.45M +282,000 New
AG
14
Artal Group
Luxembourg
$1.59M
BIT
15
BlackRock Institutional Trust
California
$1.56M -$95.1K -18,453 -6%
PI
16
Putnam Investments
Massachusetts
$1.16M
BGA
17
Belmont Global Advisors
Texas
$1.01M +$902K +175,000 New
Susquehanna International Group
18
Susquehanna International Group
Pennsylvania
$980K +$873K +169,330 New
TCIM
19
TIAA CREF Investment Management
New York
$757K
Deutsche Bank
20
Deutsche Bank
Germany
$723K +$254K +49,267 +65%
JP Morgan Chase
21
JP Morgan Chase
New York
$640K -$622K -120,613 -52%
Bank of New York Mellon
22
Bank of New York Mellon
New York
$585K +$18.3K +3,548 +4%
Jane Street
23
Jane Street
New York
$510K +$455K +88,158 New
Geode Capital Management
24
Geode Capital Management
Massachusetts
$507K +$7.51K +1,456 +2%
Ohio Public Employees Retirement System (OPERS)
25
Ohio Public Employees Retirement System (OPERS)
Ohio
$487K +$160K +31,127 +59%

CCXI Hedge Fund Activity: Q4 2013 in Review

60 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in ChemoCentryx, Inc. (CCXI) for Q4 2013, worth a combined $136M — up 16% from $117M a quarter earlier.

Sellers outnumbered buyers: 22 funds closed out of CCXI and 16 opened new positions — a net loss of 6 holders — while 16 trimmed existing stakes and 19 added.

The largest buyer was BVF Inc, adding an estimated $12.5M. The largest seller was RA Capital Management, exiting entirely with an estimated $16.9M sold.

  • 60 institutional investors held ChemoCentryx, Inc. (CCXI) as of Q4 2013, down from 66 in Q3 2013.
  • Funds reported $136M of ChemoCentryx, Inc. stock for Q4 2013, up 16% quarter-over-quarter.
  • 16 funds opened new ChemoCentryx, Inc. positions in Q4 2013 and 22 closed out, a net change of -6 holders.
  • The largest ChemoCentryx, Inc. buyer in Q4 2013 was BVF Inc, an estimated $12.5M added.
  • The largest ChemoCentryx, Inc. seller in Q4 2013 was RA Capital Management, an estimated $16.9M sold.

Based on aggregated 13F filings for Q4 2013.